|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03347 TIGERMED
Nominal 
32.350 -1.650 (-4.853%) Ranking Overview
Ranking based on 7 research report(s)
Average Ranking 2.29
|
Strong Buy (1)
0
|
Buy (2)
5
|
Hold (3)
2
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 234.00 RMB (cts) | |
| Net Profit | 2,026.51 RMB (MIL) | DPS | 56.80 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 1,347.00 | 156.00 | 30.00 | -- | 1,851.00 | 1,048.00 |
| 2025 | 1,484.00 | 170.10 | 41.65 | -- | 2,095.00 | 1,382.00 |
| 2026 | 1,779.00 | 205.70 | 47.75 | -- | 2,625.00 | 1,053.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 1,162.00 | 133.20 | 20.00 | CLSA | OutPerform | 48.60 | 30/10/2024 | |
| 2024 | 1,048.00 | 120.00 | 29.00 | HSBC | Buy | 47.40 | 20/11/2024 | |
| 2024 | 1,347.00 | 156.00 | 31.00 | UBS | Buy | 47.00 | 05/11/2024 | |
| 2024 | 1,262.00 | 145.90 | 49.00 | DAIWA | Hold | 40.00 | 06/11/2024 | |
| 2024 | 1,851.00 | 212.20 | -- | BOCI | Buy | 39.00 | 30/08/2024 | |
| 2024 | 1,504.00 | 173.80 | 42.20 | CITIGROUP | Buy | 38.50 | 31/10/2024 | |
| 2024 | 1,522.00 | 176.00 | -- | NOMURA | Neutral | 28.56 | 28/08/2024 | |
| 2025 | 1,484.00 | 170.10 | 25.50 | CLSA | -- | -- | 30/10/2024 | |
| 2025 | 1,383.00 | 159.00 | 38.00 | HSBC | -- | -- | 20/11/2024 | |
| 2025 | 2,095.00 | 242.00 | 48.00 | UBS | -- | -- | 05/11/2024 | |
| 2025 | 1,471.00 | 170.00 | 54.60 | DAIWA | -- | -- | 06/11/2024 | |
| 2025 | 1,382.00 | 158.40 | -- | BOCI | -- | -- | 30/08/2024 | |
| 2025 | 1,616.00 | 186.80 | 45.30 | CITIGROUP | -- | -- | 31/10/2024 | |
| 2025 | 1,748.00 | 202.00 | -- | NOMURA | -- | -- | 28/08/2024 | |
| 2026 | 1,660.00 | 190.30 | 28.50 | CLSA | -- | -- | 30/10/2024 | |
| 2026 | 1,641.00 | 188.00 | 45.00 | HSBC | -- | -- | 20/11/2024 | |
| 2026 | 2,625.00 | 303.00 | 61.00 | UBS | -- | -- | 05/11/2024 | |
| 2026 | 1,779.00 | 205.70 | 63.00 | DAIWA | -- | -- | 06/11/2024 | |
| 2026 | 1,053.00 | 120.60 | -- | BOCI | -- | -- | 30/08/2024 | |
| 2026 | 1,800.00 | 208.10 | 50.50 | CITIGROUP | -- | -- | 31/10/2024 | |
| 2026 | 1,926.00 | 223.00 | -- | NOMURA | -- | -- | 28/08/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 22/11/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 492,849 |
| %Change | -64.501% |
| EPS / (LPS) | RMB 0.570 |
| NBV Per Share (¥) | RMB 24.007 |